These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 31725155)
1. Identification of AbaR4 Acinetobacter baumannii resistance island in clinical isolates of blaOXA-23-positive Proteus mirabilis. Octavia S; Xu W; Ng OT; Marimuthu K; Venkatachalam I; Cheng B; Lin RTP; Teo JWP J Antimicrob Chemother; 2020 Mar; 75(3):521-525. PubMed ID: 31725155 [TBL] [Abstract][Full Text] [Related]
2. Vegetable-Derived Carbapenemase-Producing High-Risk Klebsiella pneumoniae ST15 and Acinetobacter baumannii ST2 Clones in Japan: Coexistence of Soliman AM; Nariya H; Tanaka D; Yu L; Hisatsune J; Kayama S; Kondo K; Sugai M; Shimamoto T; Shimamoto T Appl Environ Microbiol; 2021 Apr; 87(9):. PubMed ID: 33674428 [TBL] [Abstract][Full Text] [Related]
3. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015 [TBL] [Abstract][Full Text] [Related]
4. AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital. Hamidian M; Hall RM J Antimicrob Chemother; 2011 Nov; 66(11):2484-91. PubMed ID: 21873287 [TBL] [Abstract][Full Text] [Related]
5. A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate. Hamidian M; Kenyon JJ; Holt KE; Pickard D; Hall RM J Antimicrob Chemother; 2014 Oct; 69(10):2625-8. PubMed ID: 24907141 [TBL] [Abstract][Full Text] [Related]
6. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate. Girlich D; Bonnin RA; Bogaerts P; De Laveleye M; Huang DT; Dortet L; Glaser P; Glupczynski Y; Naas T Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855079 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of different carbapenemase genes among carbapenem-resistant Wang TH; Leu YS; Wang NY; Liu CP; Yan TR Antimicrob Resist Infect Control; 2018; 7():123. PubMed ID: 30338061 [TBL] [Abstract][Full Text] [Related]
10. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan. Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection. Girija SA; Priyadharsini JV; Paramasivam A Acta Microbiol Immunol Hung; 2019 Dec; 67(1):49-55. PubMed ID: 31813258 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genotypic characterization of carbapenem-resistant Abouelfetouh A; Torky AS; Aboulmagd E Antimicrob Resist Infect Control; 2019; 8():185. PubMed ID: 31832185 [TBL] [Abstract][Full Text] [Related]
16. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq. Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287 [TBL] [Abstract][Full Text] [Related]
17. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany. Lange F; Pfennigwerth N; Gerigk S; Gohlke F; Oberdorfer K; Purr I; Wohanka N; Roggenkamp A; Gatermann SG; Kaase M J Antimicrob Chemother; 2017 May; 72(5):1334-1339. PubMed ID: 28093482 [TBL] [Abstract][Full Text] [Related]
18. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan. Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428 [TBL] [Abstract][Full Text] [Related]
20. Molecular Epidemiology of Emerging Kuo SC; Huang WC; Huang TW; Wang HY; Lai JF; Chen TL; Lauderdale TL Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]